A study on COVID-19 vaccine effectiveness has finally been published after being blocked from a government health journal. The vaccine was found to be about 55% effective against COVID-19-associated ...

The study was originally meant to be published in a CDC weekly report in March.

WASHINGTON — The U.S. will likely begin distributing a third vaccine against COVID-19 in the next week, and health officials are girding for questions about which one is best. The Johnson & Johnson ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

Certain individuals with cancer were significantly more likely to survive if they received a COVID-19 mRNA vaccine, researchers at the University of Texas MD Anderson Cancer Center reported. This ...

Since the outbreak of the coronavirus disease in Wuhan, China, in December 2019, over 180 million across the world have been infected with 3.91 million others having succumbed to the disease. Known as ...

This is read by an automated voice. Please report any issues or inconsistencies here. The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their ...

A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...